Real earnings management, poison pill and IPO failure
| High-/low-growth firms | High-/low-tech firms | High/Low PMC | ||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | |
| Rm_proxy | 1.626*** | 0.126** | 1.505*** | 0.928* | 1.625*** | 0.300 |
| (3.236) | (2.023) | (2.702) | (1.789) | (3.079) | (0.542) | |
| Abs_DA | −1.252 | 0.591 | −1.551 | 0.391 | 0.488 | −2.834*** |
| (−1.220) | (0.389) | (−1.319) | (0.279) | (0.600) | (−2.580) | |
| Poison Pill | 0.465*** | 0.498** | 0.450*** | 0.445** | 0.291* | 0.642*** |
| (2.947) | (2.487) | (2.817) | (2.375) | (1.854) | (3.853) | |
| Offerprice | −0.005* | −0.006 | −0.005* | −0.006 | −0.017*** | 0.000 |
| (−1.924) | (−1.295) | (−1.921) | (−1.571) | (−3.613) | (0.094) | |
| Firstday_ret | 0.005 | −0.010 | 0.008** | −0.036*** | 0.012** | −0.001 |
| (1.625) | (−0.680) | (2.080) | (−3.137) | (2.265) | (−0.183) | |
| BTM | 0.333 | 0.348 | 0.541* | 0.309 | 0.576*** | 0.093 |
| (1.195) | (1.515) | (1.800) | (1.460) | (2.636) | (0.327) | |
| Leverage | 0.277 | −1.102*** | 0.238 | −1.099*** | −0.610** | 0.020 |
| (1.287) | (−3.869) | (1.043) | (-4.097) | (−2.419) | (0.088) | |
| Logage | 0.078 | −0.097 | 0.149 | −0.051 | 0.447*** | −0.233** |
| (0.665) | (−0.892) | (1.096) | (−0.512) | (4.202) | (−2.101) | |
| ROA | −2.225*** | −0.682 | −1.868** | −2.218* | −2.536** | −3.712*** |
| (−2.782) | (−0.506) | (−2.249) | (−1.753) | (−2.474) | (−4.141) | |
| Overhang | −0.000* | −0.000** | −0.000* | −0.000** | −0.000*** | −0.000* |
| (−1.730) | (−2.295) | (−1.802) | (−2.467) | (−3.120) | (−1.883) | |
| VC_Dummy | 0.275 | −0.125 | 0.342* | −0.285 | 0.054 | 0.412** |
| (1.503) | (−0.581) | (1.789) | (−1.413) | (0.260) | (2.448) | |
| Big4 | 0.129 | 0.001 | 0.044 | −0.096 | 0.003 | −0.138 |
| (0.824) | (0.004) | (0.277) | (−0.482) | (0.016) | (−0.884) | |
| Gross_margin | −0.938*** | 0.674* | −0.844** | 0.135 | −0.498** | −0.772** |
| (−2.866) | (1.751) | (−2.491) | (0.380) | (−2.220) | (−2.132) | |
| Nidummy | −0.184 | 0.067 | −0.035 | −0.127 | 0.041 | −0.236 |
| (−0.859) | (0.228) | (−0.157) | (−0.460) | (0.154) | (−1.018) | |
| Constant | 4.051** | 0.403 | −4.031*** | 0.791 | −4.559*** | −0.839 |
| (2.073) | (0.156) | (−4.200) | (0.426) | (−3.849) | (−0.894) | |
| Firm and year fixed effects | Yes | Yes | Yes | Yes | Yes | Yes |
| Wald χ2 | 236.51 | 293.04 | 173.35 | 338.29 | 278.56 | 175.76 |
| Log pseudolikelihood | −687.15 | −568.73 | −621.70 | −641.35 | −630.97 | −669.94 |
| Observations | 1,390 | 1,464 | 1,230 | 1,643 | 1,457 | 1,404 |
| Pseudo R2 | 0.174 | 0.238 | 0.156 | 0.247 | 0.240 | 0.165 |
| High-/low-growth firms | High-/low-tech firms | High/Low PMC | ||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | |
| Rm_proxy | 1.626*** | 0.126** | 1.505*** | 0.928* | 1.625*** | 0.300 |
| (3.236) | (2.023) | (2.702) | (1.789) | (3.079) | (0.542) | |
| Abs_DA | −1.252 | 0.591 | −1.551 | 0.391 | 0.488 | −2.834*** |
| (−1.220) | (0.389) | (−1.319) | (0.279) | (0.600) | (−2.580) | |
| Poison Pill | 0.465*** | 0.498** | 0.450*** | 0.445** | 0.291* | 0.642*** |
| (2.947) | (2.487) | (2.817) | (2.375) | (1.854) | (3.853) | |
| Offerprice | −0.005* | −0.006 | −0.005* | −0.006 | −0.017*** | 0.000 |
| (−1.924) | (−1.295) | (−1.921) | (−1.571) | (−3.613) | (0.094) | |
| Firstday_ret | 0.005 | −0.010 | 0.008** | −0.036*** | 0.012** | −0.001 |
| (1.625) | (−0.680) | (2.080) | (−3.137) | (2.265) | (−0.183) | |
| BTM | 0.333 | 0.348 | 0.541* | 0.309 | 0.576*** | 0.093 |
| (1.195) | (1.515) | (1.800) | (1.460) | (2.636) | (0.327) | |
| Leverage | 0.277 | −1.102*** | 0.238 | −1.099*** | −0.610** | 0.020 |
| (1.287) | (−3.869) | (1.043) | (-4.097) | (−2.419) | (0.088) | |
| Logage | 0.078 | −0.097 | 0.149 | −0.051 | 0.447*** | −0.233** |
| (0.665) | (−0.892) | (1.096) | (−0.512) | (4.202) | (−2.101) | |
| ROA | −2.225*** | −0.682 | −1.868** | −2.218* | −2.536** | −3.712*** |
| (−2.782) | (−0.506) | (−2.249) | (−1.753) | (−2.474) | (−4.141) | |
| Overhang | −0.000* | −0.000** | −0.000* | −0.000** | −0.000*** | −0.000* |
| (−1.730) | (−2.295) | (−1.802) | (−2.467) | (−3.120) | (−1.883) | |
| VC_Dummy | 0.275 | −0.125 | 0.342* | −0.285 | 0.054 | 0.412** |
| (1.503) | (−0.581) | (1.789) | (−1.413) | (0.260) | (2.448) | |
| Big4 | 0.129 | 0.001 | 0.044 | −0.096 | 0.003 | −0.138 |
| (0.824) | (0.004) | (0.277) | (−0.482) | (0.016) | (−0.884) | |
| Gross_margin | −0.938*** | 0.674* | −0.844** | 0.135 | −0.498** | −0.772** |
| (−2.866) | (1.751) | (−2.491) | (0.380) | (−2.220) | (−2.132) | |
| Nidummy | −0.184 | 0.067 | −0.035 | −0.127 | 0.041 | −0.236 |
| (−0.859) | (0.228) | (−0.157) | (−0.460) | (0.154) | (−1.018) | |
| Constant | 4.051** | 0.403 | −4.031*** | 0.791 | −4.559*** | −0.839 |
| (2.073) | (0.156) | (−4.200) | (0.426) | (−3.849) | (−0.894) | |
| Firm and year fixed effects | Yes | Yes | Yes | Yes | Yes | Yes |
| Wald | 236.51 | 293.04 | 173.35 | 338.29 | 278.56 | 175.76 |
| Log pseudolikelihood | −687.15 | −568.73 | −621.70 | −641.35 | −630.97 | −669.94 |
| Observations | 1,390 | 1,464 | 1,230 | 1,643 | 1,457 | 1,404 |
| Pseudo | 0.174 | 0.238 | 0.156 | 0.247 | 0.240 | 0.165 |
Note(s): The table reports the results of logistic regression for high- and low-growth firms (models 1 and 2), high- and low-tech firms (Models 3and 4) and high and low product market competition (models 5 and 6) for the whole sample over the period 1993-2015. H.G. is a dummy variable equal to 1 if the average market-to-book ratio over the entire sample period is above the sample median; otherwise, 0. High tech/low tech is a dummy variable that takes 1 if the ratio of R&D to sales is greater than 0.05. Product market competition is measured as (−1) times Herfindahl–Hirschman Index (Hj) computed as the sum of squared market shares of all firms on Compustat in an industry based on a three-digit SIC code. Market share is calculated based on the ratio of the firm i's sales to the industry j's total sales. High PMC (product market competition) is a dummy variable equal to 1 if the Herfindahl–Hirschman Index is above the median; otherwise, 0. Appendix outlines definitions and data sources for the regression variables. Robust t-statistics adjusted for clustering by the firm are reported inside the parentheses
* Statistical significance at the 10% level
** Statistical significance at the 5% level
*** Statistical significance at the 1% level
Source(s): Table by authors
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.